Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Saved in:
| Title: | Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. |
|---|---|
| Authors: | Combe B; Rheumatology, CHU Montpellier, Montpellier, France bernard.combe@umontpellier.fr., Kivitz A; Altoona Center for Clinical Research, Duncansville, Pennsylvania, USA., Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., van der Heijde D; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands., Simon JA; Köhler & Milstein Research, Mérida, Mexico., Baraf HSB; The Center for Rheumatology and Bone Research, Wheaton, Maryland, USA., Kumar U; Rheumatology, All India Institute of Medical Sciences, New Delhi, India., Matzkies F; Gilead Sciences, Foster City, California, USA., Bartok B; Gilead Sciences, Foster City, California, USA., Ye L; Gilead Sciences, Foster City, California, USA., Guo Y; Gilead Sciences, Foster City, California, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences, Foster City, California, USA.; Medicine, Duke University Medical Center, Durham, North Carolina, USA., Jahreis A; Gilead Sciences, Foster City, California, USA., Genovese MC; Gilead Sciences, Foster City, California, USA., Mozaffarian N; Ichnos Sciences, New York, New York, USA., Landewé RBM; Rheumatology and Clinical Immunology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Bae SC; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea., Keystone EC; Medicine, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada., Nash P; Griffith University, Brisbane, Queensland, Australia. |
| Source: | Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Jul; Vol. 80 (7), pp. 848-858. Date of Electronic Publication: 2021 Jan 27. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
